Skip to main content

Osiris Therapeutics, Inc. (NASDAQ: OSIR) Investor Lawsuit Over Alleged Wrongdoing In Acquisition Filed

  • Investors who purchased shares of Osiris Therapeutics, Inc. (NASDAQ: OSIR) and currently hold any of those NASDAQ: OSIR shares have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

An investor, who currently holds shares of Osiris Therapeutics, Inc. (NASDAQ: OSIR), filed a lawsuit against the takeover of Osiris Therapeutics, Inc. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ: OSIR stockholders by agreeing to sell Osiris Therapeutics, Inc. cheaply via an unfair process. On March 12, 2019, Osiris Therapeutics, Inc. (NAS...



You must register (for free) or login to view the entire case.